Welcome to our dedicated page for Helmerich & Payne SEC filings (Ticker: HP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Helmerich & Payne's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Helmerich & Payne's regulatory disclosures and financial reporting.
Helmerich & Payne, Inc. (HP) reported that executive vice president Michael Lennox sold 10,000 shares of Common Stock on September 1, 2026 at $45.00 per share in an open-market or private transaction. The filing states this sale was effected under a Rule 10b5-1 trading plan adopted on March 30, 2026. Following the transaction, Lennox directly held 171,037 shares of Helmerich & Payne common stock.
Helmerich & Payne, Inc. (HP) is the issuer for which officer Michael Lennox has filed a Form 144 notice to sell restricted securities. The notice covers a proposed sale of 10,000 shares of common stock of HP through Fidelity Brokerage Services LLC, with an aggregate sale price of $450,000.00, to be sold on the NYSE on or after September 1, 2026.
The securities to be sold were acquired through multiple restricted stock vesting compensation grants from 2019 through 2025. The filing also reports that Lennox sold 5,000 shares for $175,000.00 on July 22, 2026 and another 5,000 shares for $200,000.00 on August 10, 2026 during the prior three months.
Helmerich & Payne, Inc. (HP) director Hans Helmerich reported indirect sales of company common stock on 2026-08-20. Entities associated with him sold a total of 94,470 shares at a weighted average price of $43.90 per share, with individual sale prices ranging from $43.83 to $44.03, in open-market or private transactions. After these sales, reported indirect holdings include 471,735 shares in the reporting person's trust, 1,150,915 shares in a family trust, and 20,000 shares held by his spouse, alongside separately reported direct and other indirect holdings.
Helmerich & Payne, Inc. (symbol HP) received a notice that board member Hans Helmerich intends to sell common stock under Rule 144 through Merrill Lynch. The planned sales include 25,000 shares (aggregate market value $1,094,700), 65,000 shares ($2,846,220), and 4,470 shares ($195,732) on the NYSE.
The 25,000-share block comes from a 12/20/2012 stock option exercise. The 65,000-share and 4,470-share blocks were acquired by inheritance from Walter Helmerich III on 01/10/2012 and 03/24/2022, respectively.
Helmerich & Payne, Inc. (HP) insider Cara M. Hair, SVP, Corp. Services & CLO, reported selling 11,149 shares of common stock on 2026-08-17 in an open-market or private transaction at a weighted average price of $44.27 per share, with individual sale prices ranging from $44.21 to $44.31. After these sales, she directly holds 136,095 shares of Helmerich & Payne common stock.
Helmerich & Payne, Inc. (HP) reported that officer Sara Marie Momper, VP and Chief Accounting Officer, sold 5,054 shares of common stock on 2026-08-14 in an open-market or private transaction. The weighted average sale price was $44.28 per share, with individual sale prices ranging from $44.27 to $44.30. After these sales, she directly holds 16,958 shares of Helmerich & Payne common stock.
Cara Hair filed to sell shares of HP common stock under Rule 144. The planned sale is through Fidelity Brokerage Services LLC on the NYSE and covers 11,149 common shares, with an aggregate market value of $493,581.25 as of the filing details.
The shares to be sold include stock received from restricted stock vesting on January 11, 2022 (1,071 shares) and January 11, 2024 (10,078 shares) as compensation from the issuer. During the past three months, Hair also sold 28,345 shares of HP common stock for $1,174,904.79 on May 18, 2026.
A shareholder of HP has filed a Form 144 indicating an intention to sell 5,054 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The shares relate to multiple Restricted Stock Vesting compensation events scheduled between December 2024 and December 2025, each with specified share amounts.
Helmerich & Payne, Inc. executive Michael Lennox, EVP Western Hemisphere Land, reported selling 5,000 shares of common stock on July 22, 2026 at $35.00 per share in an open-market or private transaction. After this sale, he held 186,037 shares directly. The amendment states this transaction was effected under a Rule 10b5-1 trading plan adopted on March 30, 2026.
Helmerich & Payne, Inc. executive Michael Lennox, EVP, Western Hemisphere Land, reported selling 5,000 shares of common stock on August 10, 2026 at $40.00 per share. After this open-market sale, he directly holds 181,037 shares of Helmerich & Payne common stock. The transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by Lennox on March 30, 2026.